ORAMED PHARMACEUTICALS INC. (ORMP) Insider Trading -- Recent Executive & Director Transactions
9 insiders reported 50 Form 4 transactions for ORAMED PHARMACEUTICALS INC. (ORMP) over the past 18 months (most recent 2026-10-02). Recent activity: Hexter Joshua (COO & CBO) Sell 30,000 shares, Gabay Avraham (Chief Financial Officer) Sell 20,000 shares, KIDRON NADAV (President and CEO) Buy 349,497 shares, Kidron Miriam (Chief Scientific Officer) Buy 208,125 shares, Hexter Joshua (COO & CBO) Buy 75,455 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Hexter Joshua | COO & CBO | Sell | 30,000 | $135,330 |
| 2026-10-02 | Gabay Avraham | Chief Financial Officer | Sell | 20,000 | $90,200 |
| 2026-09-25 | KIDRON NADAV | President and CEO | Buy | 349,497 | $0 |
| 2026-09-25 | Kidron Miriam | Chief Scientific Officer | Buy | 208,125 | $0 |
| 2026-09-25 | Hexter Joshua | COO & CBO | Buy | 75,455 | $0 |
| 2026-09-25 | Gabay Avraham | Chief Financial Officer | Buy | 209,291 | $0 |
| 2026-09-25 | KIDRON NADAV | President and CEO | Buy | 368,765 | $0 |
| 2026-09-25 | Kidron Miriam | Chief Scientific Officer | Buy | 209,291 | $0 |
| 2026-09-25 | Hexter Joshua | COO & CBO | Buy | 209,291 | $0 |
| 2026-07-02 | Hexter Joshua | COO & CBO | Sell | 137,000 | $611,431 |
| 2026-07-02 | Gabay Avraham | Chief Financial Officer | Sell | 73,360 | $330,744 |
| 2026-07-02 | Hexter Joshua | COO & CBO | Buy | 50,000 | $184,500 |
| 2026-03-31 | KIDRON NADAV | President and CEO | Sell | 44,818 | $148,348 |
| 2026-03-31 | Kidron Miriam | Chief Scientific Officer | Sell | 435,084 | $1.4M |
| 2026-03-18 | Hexter Joshua | COO & CBO | Buy | 95,889 | $0 |
| 2026-03-18 | Gabay Avraham | Chief Financial Officer | Buy | 95,889 | $0 |
| 2026-03-18 | Kidron Miriam | Chief Scientific Officer | Buy | 119,558 | $0 |
| 2026-03-18 | KIDRON NADAV | President and CEO | Buy | 167,005 | $0 |
| 2026-03-16 | KIDRON NADAV | President and CEO | Sell | 100,000 | $0 |
| 2026-01-29 | Hexter Joshua | COO & CBO | Buy | 19,000 | $0 |
| 2026-01-29 | Gabay Avraham | Chief Financial Officer | Buy | 19,000 | $0 |
| 2026-01-29 | Kidron Miriam | Chief Scientific Officer | Buy | 19,000 | $0 |
| 2026-01-29 | KIDRON NADAV | President and CEO | Buy | 109,000 | $0 |
| 2026-01-21 | Kidron Miriam | Chief Scientific Officer | Sell | 86,166 | $0 |
| 2026-01-05 | Kidron Miriam | Chief Scientific Officer | Buy | 121,331 | $0 |
Source: SEC Form 4 filings · as of 2026-10-02